20-HETE contributes to the acute fall in cerebral blood flow after subarachnoid hemorrhage in the rat

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 282, Issue 4 51-4, 2002, Pages

  Kehl, Franz ^a,b,c   Cambj Sapunar, Liana ^a,b,c   Maier, Kristopher G ^a,b,c   Miyata, Noriyuki ^a,b,c   Kametani, Shunishi ^a,b,c   Okamoto, Hirotsugu ^a,b,c   Hudetz, Anthony G ^a,b,c   Schulte, Marie L ^a,b,c   Zagorac, Drazen ^a,b,c   Harder, David R ^a,b,c   Roman, Richard J ^a,b,c  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Department of Anesthesiology ^*  (United States)

^c TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

20 hydroxyeicosatetraenoic acid; CYP4A; Stroke

Indexed keywords

17 OCTADECYNOIC ACID; 20 HYDROXYICOSATETRAENOIC ACID; CYTOCHROME P450; FORMAMIDINE; N HYDROXY N' (4 BUTYL 2 METHYLPHENYL)FORMAMIDINE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL BLOOD; ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CEREBROSPINAL FLUID; CISTERNA MAGNA; CONCENTRATION RESPONSE; CONTROLLED STUDY; IC 50; KIDNEY MICROSOME; LASER DOPPLER FLOWMETRY; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SUBARACHNOID HEMORRHAGE;

EID: 0036087904     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00924.2001     Document Type: Article

References (45)

1. 20-HETE agonists and antagonists in the renal circulation
2. Contribution of 20-HETE to vasodilator actions of nitric oxide in the cerebral microcirculation
3. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand: Incidence and case fatality from the Australian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS)
4. Cortical blood flow and cerebral perfusion pressure in a new noncraniotomy model of subarachnoid hemorrhage in the rat
5. 16(R)-hydroxy-5,8,11,14-eicosatetraenoic acid, a new arachidonate metabolite in human polymorphonuclear leukocytes
6. The biphasic response of cerebral vasospasm in experimental subarachnoid hemorrhage
7. Initial and recurrent bleeding are the major causes of death following subarachnoid hemorrhage
8. Regulation of preglomerular microvascular 20-hydroxieicosatetraenoic acid levels by salt depletion
9. A receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection
10. Mechanisms of cerebral vasospasm in subarachnoid haemorrhage
11. Angiotensin II releases 20-HETE from rat renal microvessels
12. Effect of experimental subarachnoid hemorrhage on CSF eicosanoids in the rat
13. Subarachnoid haemorrhage in the rat: Angiography and fluorescence microscopy of the major cerebral arteries
14. Regulation of the cerebral circulation: Role of endothelium and potassium channels
15. Production of 20-HETE and its role in autoregulation of cerebral blood flow
16. 2+ current
17. Lactate and free fatty acids after subarachnoid hemorrhage
18. Formation and action of a P-450 4A metabolite of arachidonic acid in cat cerebral microvessels
19. Cytochrome P450 metabolites of arachidonic acid as intracellular signaling molecules in vascular tissue
20. Video microscopy of cerebrocortical capillary flow: Response to hypotension and intracranial hypertension
21. A multinational comparison of subarachnoid hemorrhage epidemiology in the WHO MONICA stroke study
22. The time course of intracranial pathophysiological changes following experimental subarachnoid haemorrhage in the rat
23. Plasma endothelin concentrations after aneurysmal subarachnoid hemorrhage
24. Combination of serine protease inhibitor FUT-175 and thromboxane synthetase inhibitor OKY-046 decreases cerebral vasospasm in patients with subarachnoid hemorrhage
25. 20-Hydroxyeicosatetraenoic acid-induced vasoconstriction and inhibition of potassium current in cerebral vascular smooth muscle is dependent on activation of protein kinase C
26. Formation of 20-hydroxieicosatetraenoic acid, a vasoactive and natriuretic eicosanoid, in human kidney. Role of Cyp 4F2 and Cyp4A11
27. Altered renal P-450 metabolism of arachidonic acid in Dahl salt-sensitive rats
28. A review of hemoglobin and the pathogenesis of cerebral vasospasm
29. Fluorescent HPLC assay for 20-HETE and other P-450 metabolites of arachidonic acid
30. HET 0016, a potent and selective inhibitor of 20-HETE synthesis enzyme
31. Renal oxygenases: Differential contribution to vasoconstriction induced by ET-1 and ANG II
32. Metabolism of arachidonic acid to 20-hydroxy-5,8,11,14-eicosatetraenoic acid P450 enzymes in human liver: Involvement of CYP4F2 and CYP4A11
33. Metabolism of arachidonic acid by canine polymorphonuclear leukocytes synthesis of lipoxygenase and ω-oxidized metabolites
34. Effects of S-nitrosoglutathione on acute vasoconstriction and glutamate release after subarachnoid hemorrhage
35. Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma
36. Subarachnoid haemorrhage: What happens to the cerebral arteries?
37. Effect of subarachnoid hemorrhage on dilatation of rat basilar artery in vivo
38. Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid hemorrhage
39. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: A new animal model
40. Subarachnoid hemorrhage-factors in prognosis and management
41. Role of cGMP versus 20-HETE in the vasodilator response to nitric oxide in rat cerebral arteries
42. Effects of thromboxane synthetase inhibitor (RS-5186) on experimentally-induced cerebral vasospasm
43. Arachidonic acid metabolism modulates vasopressin-induced renal vasoconstriction
44. Novel mechanism by which hemoglobin induces constriction of cerebral arteries
45. Effects of 17-octadecynoic acid, a suicide-substrate inhibitor of cytochrome P450 fatty acid ω-hydroxylase, on renal function in rats